Overview

Short-term Metabolic Effects of Mirtazapine in Healthy Subjects

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine metabolic changes upon a 7 day medication of 30 mg mirtazapine per day in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Max-Planck-Institute of Psychiatry
Treatments:
Mianserin
Mirtazapine